Trust Company’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.32K Buy
113
+112
+11,200% +$2.56K ﹤0.01% 536
2026
Q1
$22 Hold
1
﹤0.01% 903
2025
Q4
$12 Buy
+1
New +$13 ﹤0.01% 888
2020
Q4
Sell
-16
Closed -$1K 293
2020
Q3
$1K Sell
16
-40
-71% -$772 ﹤0.01% 305
2020
Q2
$1K Hold
56
﹤0.01% 286
2020
Q1
$1K Buy
56
+40
+250% +$577 ﹤0.01% 277
2019
Q4
$1K Hold
16
﹤0.01% 278
2019
Q3
$1K Hold
16
﹤0.01% 308
2019
Q2
$1K Hold
16
﹤0.01% 291
2019
Q1
$1K Hold
16
﹤0.01% 320
2018
Q4
$1K Hold
16
﹤0.01% 306
2018
Q3
$1K Buy
+16
New +$700 ﹤0.01% 329
2016
Q2
Sell
-16
Closed 351
2016
Q1
$0 Sell
16
-10
-38% -$50 ﹤0.01% 346
2015
Q4
$139 Sell
26
-80
-75% -$511 ﹤0.01% 341
2015
Q3
$1K Buy
+106
New +$1.11K ﹤0.01% 360

Other funds holding CC

Trust Company's CC Position: Q2 2026 in Review

Trust Company increased its Chemours (CC) stake by 11,200% in Q2 2026, buying an estimated $2.56K and bringing the position to 113 shares worth $2.32K. The position accounts for ﹤0.01% of the portfolio, ranked #536.

Trust Company first reported a position in CC in Q3 2015 and has held it in 15 quarters since. 58 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Trust Company held 113 shares of Chemours worth $2.32K as of Q2 2026.
  • Trust Company bought 112 Chemours shares in Q2 2026, an estimated $2.56K.
  • Chemours made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #536 holding.
  • Trust Company first reported a position in Chemours in Q3 2015 and has held it in 15 quarters since.
  • 58 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.